RBII - Rising BioSciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0007
0.0000 (0.00%)
At close: 12:05PM EDT
Stock chart is not supported by your current browser
Previous Close0.0007
Open0.0006
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0006 - 0.0007
52 Week Range0.0006 - 0.0097
Volume2,854,000
Avg. Volume7,718,101
Market Cap468,107
Beta (3Y Monthly)20.75
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE

    Rising Biosciences, Inc. Announces TSW! (This "Stuff" Works!) Topical Pain Cream With CBD To Enter Pilot Production Run, Gov. of Ohio Legalizes Hemp and CBD Products Statewide

    SANDUSKY, OH / ACCESSWIRE / August 1, 2019 / Rising Biosciences, Inc. (OTC PINK:RBII) (“Rising Biosciences” or the “Company”) an emerging leader in the research and development of oral and topical pharmaceuticals produced according to the strict standards of the pharmaceutical compounding industry, announces that TSW! (This “stuff” Works!) Topical Pain Relief Cream With CBD (“TSW! Pain Cream CBD”) will enter into pilot production. Rising Biosciences is also excited to announce that TSW! Pain Cream CBD will be available for distribution to markets in its home state of Ohio, due to the passage of a bill on July 30, 2019 which allows legal manufacturing and sale of Hemp and CBD products within the state of Ohio.

  • ACCESSWIRE

    Rising Biosciences Inc. Issues Progress Update on SNB Health Subsidiary: Expanded Outpatient Staffing to Handle Increased Client Demand and Closing Date Set for Sandusky Inpatient Facility Southern Northern Behavioral Health, Inc. (SNB Health)

    SANDUSKY, OH / ACCESSWIRE / July 29, 2019 / Rising Biosciences, Inc. (OTC PINK: RBII) (“Rising Biosciences” or the “Company”) is pleased to update shareholders on recent progress made by its wholly owned subsidiary, Southern Northern Behavioral Health, Inc. (SNB Health). Due to rising client demand, SNB Health is currently hiring and training new staff, which is expected to greatly increase its outpatient treatment capacity in coming months. The company has been under contract to acquire a 40,000 square foot facility for use as a full services inpatient medical treatment facility for the treatment of patients suffering from substance addiction disorders, as announced on June 14th of this year.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 7/19

    HOLLYWOOD, CA / ACCESSWIRE / July 19, 2019 / Water solutions, solar power, opioid treatment, waste recycling, Twitter universe ; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...

  • ACCESSWIRE

    Rising Biosciences Inc. Announces CBD Only Variant of Cannophen(TM) Begins Pilot Production Run, Coming to Market Soon

    SANDUSKY, OH / ACCESSWIRE / July 16, 2019 / Rising Biosciences, Inc. (OTC Pink: RBII) (“Rising Biosciences” or the “Company”) is pleased to announce that a CBD only variant of Cannophen™ Capsules and Vape Cartridges has entered into an initial production run. Cannophen™ is Rising Biosciences’ flagship product. Cannophen™ oral capsules and vape cartridges have been developed using strict standards set forward by the pharmaceutical compounding industry.

  • ACCESSWIRE

    MoneyTV with Donald Baillargeon, 6/28

    HOLLYWOOD, CA / ACCESSWIRE / June 28, 2019 / Hemp flower, CBD opioid treatment, water pump stations, financial victimization, POTUS candidates' free for all; this week on MoneyTV with Donald Baillargeon. ...

  • GlobeNewswire

    Rising Biosciences Inc. Acquires SNB Health, Signs Contract to Purchase 40,000 Sq. Ft. Facility for Behavioral Health Addiction Treatment Inpatient Center

    SANDUSKY, Ohio, June 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE — Rising Biosciences, Inc. (RBII) is pleased to announce the recent acquisition of Southern Northern Behavioral Health, Inc. (SNB Health) a growing substance abuse treatment company, as a wholly owned subsidiary.

  • GlobeNewswire

    Rising Biosciences Inc. Announces New Partnership in Addition to Naming New COO

    SANDUSKY, Ohio, March 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE - - Rising Biosciences Inc. (RBII), a research development pharmaceutical and physicians practice management company, is pleased to announce a new partnership with Three Seven Management in addition to naming Christopher Will as the new COO of RBII. Mr. Will provided integral leadership since inception in the development of the current operating model that was implemented in all clinics.   Daily operations and management of the clinics as well as the pharmaceutical research and development unit will be guided under the leadership of COO Will.

  • GlobeNewswire

    PAOG Officially Appoints Karl Riedel as New CEO and President

    SANDUSKY, Ohio, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PAO Group, Inc. (OTC: PAOG), a holdings company dedicated to alternative patient care treatments including the proper use of medical cannabis, and through its subsidiaries who are currently growing medical cannabis in the state of Michigan and pursuing additional MMFLA licensing through LARA for the cultivation, processing, and transportation of medical and recreational cannabis, is pleased to announce that Arthur Hall has officially stepped down and has fully passed the PAOG leadership torch to CEO Karl Riedel and Riedel's management team.

  • GlobeNewswire

    PAO Group Holds Shareholder Conference Call with Incoming CEO to Share His Vision for the Company

    SANDUSKY, Ohio, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – PAO Group, Inc. (PAOG) recently held a shareholder conference call on January 16, 2019, where Interim CEO Arthur Hall introduced Incoming CEO Karl Riedel to share his vision for the company. Incoming CEO Karl Riedel is excited to be talking the helm of PAOG. Riedel discussed his plans to take PAO Group, Inc. in a new direction following its recent transfer of alternative medical centers to Rising Biosciences, Inc. (RBII).  He assured shareholders that the new direction of PAOG remains in line with the original mission of the company, which is to provide patient relief through alternative medicines including cannabis treatment.

  • GlobeNewswire

    (CORRECTION) Rising Biosciences Set To Acquire All Assets from PAO Group / Announces Management Change

    SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry and the FDA, is pleased to announce that the Company has reached an agreement with PAO Group (PAOG) to acquire all current assets including PAO's medical clinics located in Florida, Pennsylvania and Ohio.

  • GlobeNewswire

    Rising Biosciences Set To Acquire All Assets from PAO Group

    SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry and the FDA, is pleased to announce that the Company has reached an agreement with PAO Group (PAOG) to acquire all current assets including PAO's medical clinics located in Florida, Pennsylvania and Ohio. Company COO Arthur Hall will be stepping up as President and CEO of Rising Biosciences and interim President and CEO PAO Group as Mr. Robert Webber will be stepping down from both companies to pursue other opportunities.  We would like to thank Mr. Webber for his efforts and services of both companies.